The protective effects of a dietary carotenoid, astaxanthin, against light-induced retinal damage

Journal of Pharmacological Sciences

Volumn 123, Issue 3, 2013, Pages 209-218

  Otsuka, Tomohiro ^a   Shimazawa, Masamitsu ^a   Nakanishi, Tomohiro ^a   Ohno, Yuta ^a   Inoue, Yuki ^a   Tsuruma, Kazuhiro ^a   Ishibashi, Takashi ^b   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b JAPAN ENERGY CORPORATION   (Japan)

Author keywords

Age related macular degeneration; Astaxanthin; Oxidative stress; Photoreceptor; Retinitis pigmentosa

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ASTAXANTHIN; COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; METALLOTHIONEIN II; METALLOTHIONEIN III; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRORETINOGRAM; EYE PROTECTION; GENE; GENE EXPRESSION; IN VIVO STUDY; LIGHT EXPOSURE; MALE; MOUSE; MT II GENE; MT III GENE; NONHUMAN; OUTER NUCLEAR LAYER THICKNESS; PROTEIN EXPRESSION; RETINA INJURY; SOD1 GENE; VISUAL SYSTEM PARAMETERS;

ADMINISTRATION, OPHTHALMIC; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELLS, CULTURED; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; LIGHT; MACULAR DEGENERATION; MALE; MICE; MICE, INBRED STRAINS; PROPIDIUM; REACTIVE OXYGEN SPECIES; RETINA; RETINAL CONE PHOTORECEPTOR CELLS; RETINITIS PIGMENTOSA; XANTHOPHYLLS;

EID: 84890541445     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13066FP     Document Type: Article

References (50)

1. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.
2. Hirakawa M, Tanaka M, Tanaka Y, Okubo A, Koriyama C, Tsuji M, et al. Age-related maculopathy and sunlight exposure evaluated by objective measurement. Br J Ophthalmol. 2008; 92:630-634.
3. Paskowitz DM, LaVail MM, Duncan JL. Light and inherited retinal degeneration. Br J Ophthalmol. 2006;90:1060-1066.
4. Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats. Invest Ophthalmol. 1966;5:450-473.
5. Nickells RW, Zack DJ. Apoptosis in ocular disease: a molecular overview. Ophthalmic Genet. 1996;17:145-165.
6. Yang JH, Basinger SF, Gross RL, Wu SM. Blue light-induced generation of reactive oxygen species in photoreceptor ellipsoids requires mitochondrial electron transport. Invest Ophthalmol Vis Sci. 2003;44:1312-1319.
7. Godley BF, Shamsi FA, Liang FQ, Jarrett SG, Davies S, Boulton M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J Biol Chem. 2005;280: 21061-21066.
8. Yamashita H, Horie K, Yamamoto T, Nagano T, Hirano T. Lightinduced retinal damage in mice. Hydrogen peroxide production and superoxide dismutase activity in retina. Retina. 1992;12: 59-66.
9. Hashizume K, Hirasawa M, Imamura Y, Noda S, Shimizu T, Shinoda K, et al. Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol. 2008;172: 1325-1331.
10. Organisciak DT, Darrow RA, Barsalou L, Darrow RM, Lininger LA. Light-induced damage in the retina: differential effects of dimethylthiourea on photoreceptor survival, apoptosis and DNA oxidation. Photochem Photobiol. 1999;70:261-268.
11. Ranchon I, Chen S, Alvarez K, Anderson RE. Systemic administration of phenyl-N-tert-butylnitrone protects the retina from light damage. Invest Ophthalmol Vis Sci. 2001;42:1375-1379.
12. Tanito M, Li F, Elliott MH, Dittmar M, Anderson RE. Protective effect of TEMPOL derivatives against light-induced retinal damage in rats. Invest Ophthalmol Vis Sci. 2007;48:1900-1905.
13. Kurashige M, Okimasu E, Inoue M, Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR. 1990;22:27-38.
14. O'Connor I, O'Brien N. Modulation of UVA light-induced oxidative stress by beta-carotene, lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci. 1998;16:226-230.
15. Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W, et al. Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb. 2000;7:216-222.
16. Kobayashi M. In vivo antioxidant role of astaxanthin under oxidative stress in the green alga Haematococcus pluvialis. Appl Microbiol Biotechnol. 2000;54:550-555.
17. Aoi W, Naito Y, Sakuma K, Kuchide M, Tokuda H, Maoka T, et al. Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal. 2003;5: 139-144.
18. Chew BP, Park JS, Wong MW, Wong TS. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res. 1999;19:1849-1853.
19. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, et al. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci. 2003;44:2694-2701.
20. Uchiyama K, Naito Y, Hasegawa G, Nakamura N, Takahashi J, Yoshikawa T. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice. Redox Rep. 2002;7:290-293.
21. Kang JO, Kim SJ, Kim H. Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CCl4-treated rats. Methods Find Exp Clin Pharmacol. 2001; 23:79-84.
22. Okai Y, Higashi-Okai K. Possible immunomodulating activities of carotenoids in in vitro cell culture experiments. Int J Immunopharmacol. 1996;18:753-758.
23. Miyawaki H, Takahashi J, Tsukahara H, Takehara I. Effects of astaxanthin on human blood rheology. J Clin Biochem Nutr. 2008;43:69-74.
24. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, et al. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci. 2008;49:1679-1685.
25. Nakajima Y, Inokuchi Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol. 2008;60:1365-1374.
26. Matsunaga N, Imai S, Inokuchi Y, Shimazawa M, Yokota S, Araki Y, et al. Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo. Mol Nutr Food Res. 2009;53:869-877.
27. Imai S, Inokuchi Y, Nakamura S, Tsuruma K, Shimazawa M, Hara H. Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. Eur J Pharmacol. 2010;642:77-85.
28. Tsuruma K, Shimazaki H, Ohno Y, Inoue Y, Honda A, Imai S, et al. Metallothionein-III deficiency exacerbates light-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2012;53:7896-7903.
29. Showalter LA, Weinman SA, Osterlie M, Lockwood SF. Plasma appearance and tissue accumulation of non-esterified, free astaxanthin in C57BL/6 mice after oral dosing of a disodium disuccinate diester of astaxanthin (Heptax). Comp Biochem Physiol C Toxicol Pharmacol. 2004;137:227-236.
30. Mercke Odeberg J, Lignell A, Pettersson A, Hoglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci. 2003;19:299-304.
31. Stewart JS, Lignell A, Pettersson A, Elfving E, Soni MG. Safety assessment of astaxanthin-rich microalgae biomass: Acute and subchronic toxicity studies in rats. Food Chem Toxicol. 2008; 46:3030-3036.
32. Ono A, Sekita K, Saitoh M, Umemura T, Ogawa Y, Furuya T, et al. [A 13-week subchronic oral toxicity study of haematococcus color in F344 rats]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 1999;91-98. (text in Japanese)
33. Spiller GA, Dewell A. Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial. J Med Food. 2003;6:51-56.
34. Satoh A, Tsuji S, Okada Y, Murakami N, Urami M, Nakagawa K, et al. Preliminary clinical evaluation of toxicity and efficacy of a new astaxanthin-rich Haematococcus pluvialis extract. J Clin Biochem Nutr. 2009;44:280-284.
35. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. Embo J. 1991;10:2247-2258.
36. Lo YY, Cruz TF. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem. 1995;270:11727-11730.
37. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990;265: 659-665.
38. Shigenaga MK, Ames BN. Assays for 8-hydroxy-2'-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic Biol Med. 1991;10:211-216.
39. Wu Y, Yanase E, Feng X, Siegel MM, Sparrow JR. Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc Natl Acad Sci U S A. 2010;107:7275-7280.
40. Fukuzawa K, Inokami Y, Tokumura A, Terao J, Suzuki A. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposomes. Lipids. 1998;33:751-756.
41. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Involvement of oxidative mechanisms in blue-light- induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci. 2002;43:1222-1227.
42. Johnson EA, Schroeder WA. Microbial carotenoids. Adv Biochem Eng Biotechnol. 1996;53:119-178.
43. Hama S, Takahashi K, Inai Y, Shiota K, Sakamoto R, Yamada A, et al. Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage. J Pharm Sci. 2012;101:2909-2916.
44. Chang Q, Peter ME, Grassi MA. Fas ligand-Fas signaling participates in light-induced apoptotic death in photoreceptor cells. Invest Ophthalmol Vis Sci. 2012;53:3703-3716.
45. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005; 24:275-306.
46. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 2001;8:569-581.
47. Yamamoto M, Lidia K, Gong H, Onitsuka S, Kotani T, Ohira A. Changes in manganese superoxide dismutase expression after exposure of the retina to intense light. Histochem J. 1999;31: 81-87.
48. Thornalley PJ, Vasak M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta. 1985;827:36-44.
49. Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101:58D-68D.
50. Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev. 2011;16: 355-364.